Skip to main content
Clinical Trials/NCT04486729
NCT04486729
Unknown
Not Applicable

Respiratory System Mechanics and Gas Exchange Characteristics Applying Different Ventilatory Strategies in Patients With SARS-CoV-2

Sanatorio Anchorena San Martin1 site in 1 country15 target enrollmentJuly 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid19
Sponsor
Sanatorio Anchorena San Martin
Enrollment
15
Locations
1
Primary Endpoint
Driving transpulmonary pressure (cmH2O)
Last Updated
5 years ago

Overview

Brief Summary

The combination of different ventilatory strategies and its effects on respiratory mechanics and gas exchange in patients under mechanical ventilation with acute respiratory distress syndrome secondary to coronavirus-19 has been scarcely described.

Detailed Description

Investigation in mechanically ventilated patients with with acute respiratory distress syndrome (ARDS) secondary to coronavirus-19 (COVID-19) is emerging due to presumed differences with typical ARDS from other origin. Considering these issues, the effects of ventilatory strategies such as positive end expiratory pressure, end inspiratory pause and fraction of inspired oxygen on respiratory mechanics and gas exchange must be studied in order to characterize the behavior of COVID-19 ARDS during invasive mechanical ventilation and choose the best combination of ventilatory settings. In this study the investigators will evaluate the changes in respiratory mechanics and gas exchange produced by low and high positive end expiratory pressure, low and high inspired oxygen fraction and the application of end inspiratory pause during volume controlled mechanical ventilation.

Registry
clinicaltrials.gov
Start Date
July 1, 2020
End Date
October 20, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Sanatorio Anchorena San Martin
Responsible Party
Principal Investigator
Principal Investigator

Matias Accoce

Head of physical therapy department

Sanatorio Anchorena San Martin

Eligibility Criteria

Inclusion Criteria

  • Older than 18 years old
  • less than 72 hs since ARDS diagnosis
  • Moderate to severe ARDS
  • central venous catheter and arterial line available
  • Need of neuromuscular blocking agents
  • Supine position
  • Informed consent accepted
  • Airway opening pressure lower than 20 cmH2O

Exclusion Criteria

  • RASS target higher than -5
  • COPD diagnosis
  • Pneumothorax
  • Intracraneal Hypertension
  • Pregnancy
  • Cardiac inssuficiency uncompensated
  • Chest wall deformity
  • Bronchopleural fistula
  • Contraindication to use esophageal manometry

Outcomes

Primary Outcomes

Driving transpulmonary pressure (cmH2O)

Time Frame: 10 minutes

The driving transpulmonary pressure will be evaluated between the high and low PEEP condition using the formula: driving transpulmonary pressure = driving airway pressure - driving esophageal pressure (cmH2O).

Bohr dead space fraction (%)

Time Frame: 10 minutes

The Bohr dead space fraction will be evaluated with high PEEP between the condition with end inspiratory pause and with no end inspiratory pause application using the formula: Bohr dead space fraction = Alveolar pressure of CO2 (PACO2) - Expired pressure of CO2 (PECO2) / PACO2

Shunt fraction (%)

Time Frame: 10 minutes

The shunt fraction will be evaluated with low PEEP between the condition with high fraction of oxygen to achieve a saturation goal of 96-98% and the condition with low fraction of oxygen to achieve a saturation goal of 88-92%. The shunt fraction will be calculated using the formula: Qs/Qt = (capillary oxygen content - arterial oxygen content)/(capillary oxygen content - venous oxygen content)

Study Sites (1)

Loading locations...

Similar Trials